Sarepta Therapeutics, Inc. — Director's Dealing 2021

Sep 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-09-08

Reporting Person: Estepan Ian Michael (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-08	Common Stock	F	1623	$78.29	Disposed	26753	Direct

Footnotes

F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock.